Deardorf Caren - Insider Non-Derivative Transactions at Crinetics Pharmaceuticals, Inc. (CRNX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 7, 2024, Deardorf Caren's relationship to Crinetics Pharmaceuticals, Inc. (CRNX) is Director, and currently has 9,400 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CRNX insiders.
Data Source: SEC.
Deardorf Caren - Insider Non-Derivative Transactions of CRNX Common Stock
Deardorf Caren - Insider Non-Derivative Transactions at CRNX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 8, 2024 | Acquisition -- (Common Stock) | 3400 | 0 | 9400 |
| Jun 17, 2023 | Acquisition -- (Common Stock) | 6000 | 0 | 6000 |